ALBERTDAVD Stock Overview
Manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable syringes and needles in India.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 5/6 |
Albert David Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,152.70 |
| 52 Week High | ₹1,607.90 |
| 52 Week Low | ₹558.20 |
| Beta | 0.33 |
| 1 Month Change | -2.83% |
| 3 Month Change | -13.94% |
| 1 Year Change | 103.12% |
| 3 Year Change | 135.53% |
| 5 Year Change | 134.98% |
| Change since IPO | 269.16% |
Recent News & Updates
Recent updates
We Think That There Are Issues Underlying Albert David's (NSE:ALBERTDAVD) Earnings
May 21
Positive Sentiment Still Eludes Albert David Limited (NSE:ALBERTDAVD) Following 25% Share Price Slump
Mar 20The Market Lifts Albert David Limited (NSE:ALBERTDAVD) Shares 33% But It Can Do More
Jan 20Albert David (NSE:ALBERTDAVD) Will Pay A Dividend Of ₹9.00
Jul 04Albert David (NSE:ALBERTDAVD) Is Paying Out A Dividend Of ₹9.00
May 22Here's Why We Think Albert David (NSE:ALBERTDAVD) Is Well Worth Watching
Feb 14We Think Shareholders Are Less Likely To Approve A Large Pay Rise For Albert David Limited's (NSE:ALBERTDAVD) CEO For Now
Sep 08Calculating The Intrinsic Value Of Albert David Limited (NSE:ALBERTDAVD)
Feb 06Do Fundamentals Have Any Role To Play In Driving Albert David Limited's (NSE:ALBERTDAVD) Stock Up Recently?
Jan 22
Why Albert David's (NSE:ALBERTDAVD) CEO Pay Matters
Jan 07Have Insiders Been Buying Albert David Limited (NSE:ALBERTDAVD) Shares?
Dec 23Here's Why Albert David's (NSE:ALBERTDAVD) Statutory Earnings Are Arguably Too Conservative
Dec 08Should You Or Shouldn't You: A Dividend Analysis on Albert David Limited (NSE:ALBERTDAVD)
Nov 23A Look At The Intrinsic Value Of Albert David Limited (NSE:ALBERTDAVD)
Nov 08Should Weakness in Albert David Limited's (NSE:ALBERTDAVD) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
Oct 13Is Now The Time To Put Albert David (NSE:ALBERTDAVD) On Your Watchlist?
Sep 28What Does Albert David's (NSE:ALBERTDAVD) CEO Pay Reveal?
Sep 13Are Insiders Buying Albert David Limited (NSE:ALBERTDAVD) Stock?
Aug 28Should You Buy Albert David Limited (NSE:ALBERTDAVD) For Its Dividend?
Aug 10A Look At The Fair Value Of Albert David Limited (NSE:ALBERTDAVD)
Aug 10Albert David Limited (NSE:ALBERTDAVD) Might Not Be As Mispriced As It Looks
Jul 20Shareholder Returns
| ALBERTDAVD | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -1.9% | 1.5% | 3.0% |
| 1Y | 103.1% | 63.0% | 44.6% |
Return vs Industry: ALBERTDAVD exceeded the Indian Pharmaceuticals industry which returned 63% over the past year.
Return vs Market: ALBERTDAVD exceeded the Indian Market which returned 44.6% over the past year.
Price Volatility
| ALBERTDAVD volatility | |
|---|---|
| ALBERTDAVD Average Weekly Movement | 6.1% |
| Pharmaceuticals Industry Average Movement | 5.8% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in IN Market | 9.5% |
| 10% least volatile stocks in IN Market | 4.1% |
Stable Share Price: ALBERTDAVD has not had significant price volatility in the past 3 months.
Volatility Over Time: ALBERTDAVD's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1938 | 1,271 | Umesh Kunte | www.albertdavidindia.com |
Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, bulk drugs, and disposable syringes and needles in India. It offers formulations for parenterals, oral/enteral, topical agents, and vision care products. The company exports its products to Latin American, Southeast Asian, and other African countries.
Albert David Limited Fundamentals Summary
| ALBERTDAVD fundamental statistics | |
|---|---|
| Market cap | ₹6.58b |
| Earnings (TTM) | ₹754.20m |
| Revenue (TTM) | ₹4.20b |
8.7x
P/E Ratio1.6x
P/S RatioIs ALBERTDAVD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ALBERTDAVD income statement (TTM) | |
|---|---|
| Revenue | ₹4.20b |
| Cost of Revenue | ₹1.26b |
| Gross Profit | ₹2.94b |
| Other Expenses | ₹2.18b |
| Earnings | ₹754.20m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 132.15 |
| Gross Margin | 69.91% |
| Net Profit Margin | 17.96% |
| Debt/Equity Ratio | 0.5% |
How did ALBERTDAVD perform over the long term?
See historical performance and comparisonDividends
0.8%
Current Dividend Yield14%
Payout RatioDoes ALBERTDAVD pay a reliable dividends?
See ALBERTDAVD dividend history and benchmarks| Albert David dividend dates | |
|---|---|
| Ex Dividend Date | Aug 02 2024 |
| Dividend Pay Date | Sep 08 2024 |
| Days until Ex dividend | 71 days |
| Days until Dividend pay date | 108 days |
Does ALBERTDAVD pay a reliable dividends?
See ALBERTDAVD dividend history and benchmarks